Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 24, 2015
Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy
Jacqueline A Hawkins-Salsbury, Lauren Shea, Xuntian Jiang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 24, 2020
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma
Lauren Shea, Marcus P Watkins, Fei Wan, et al.
Cancer Genetics
|
March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors
Felicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
Blood Advances
|
June 14, 2023
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Reem Karmali, et al.
Blood Cancer Journal
|
March 27, 2025
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers
Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka, et al.
Journal of Hematology & Oncology
|
May 9, 2023
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
Narendranath Epperla, Rina Li Welkie, Pallawi Torka, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 24, 2015
Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy
Jacqueline A Hawkins-Salsbury, Lauren Shea, Xuntian Jiang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 24, 2020
A Pilot Study of Lenalidomide Maintenance Therapy after Autologous Transplantation in Relapsed or Refractory Classical Hodgkin Lymphoma
Lauren Shea, Marcus P Watkins, Fei Wan, et al.
Cancer Genetics
|
March 6, 2026
Exome sequencing of Hodgkin and non-Hodgkin composite lymphomas identifies shared somatic mutations indicative of common founding precursors
Felicia Gomez, Lauren Shea, Sivasankar Annamalai Sharavanan, et al.
Blood Advances
|
June 14, 2023
Impact of detectable monoclonal protein at diagnosis on outcomes in marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Reem Karmali, et al.
Blood Cancer Journal
|
March 27, 2025
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers
Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka, et al.
Journal of Hematology & Oncology
|
May 9, 2023
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study
Narendranath Epperla, Rina Li Welkie, Pallawi Torka, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2022
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Steven M Horwitz, Stephen Ansell, Weiyun Z Ai, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Page
of 2